SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-034374
Filing Date
2023-02-13
Accepted
2023-02-13 08:11:03
Documents
14
Period of Report
2023-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d458557d8k.htm   iXBRL 8-K 25329
2 EX-99.1 d458557dex991.htm EX-99.1 5320
6 GRAPHIC g458557g0213043917088.jpg GRAPHIC 5164
  Complete submission text file 0001193125-23-034374.txt   158505

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20230213.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20230213_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20230213_pre.xml EX-101.PRE 10812
8 EXTRACTED XBRL INSTANCE DOCUMENT d458557d8k_htm.xml XML 3273
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 23614822
SIC: 2834 Pharmaceutical Preparations